W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne
Clinical trial NCT01132443 · COMPLETED
Trial details
- NCT number
- NCT01132443
- Sponsor
- Stiefel, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-06
- Primary completion
- 2010-06-12
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.